We are live on ! Find out more
PCM

Pavaki Capital Management Portfolio holdings

AUM $287M
This Fund
S&P 500
This Quarter Est. Return
+11.86%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$287M
AUM Growth
+$51.4M
Cap. Flow
+$39.9M
Cap. Flow %
13.9%
Top 10 Hldgs %
50.36%
Holding
177
New
21
Increased
16
Reduced
3
Closed
14

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$13.4M
2
QCOM icon
Qualcomm
QCOM
+$9.16M
3
CVX icon
Chevron
CVX
+$4.19M
4
TXT icon
Textron
TXT
+$3.78M
5
MU icon
Micron Technology
MU
+$3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$9.71M
2
DIS icon
Walt Disney
DIS
+$6.12M
3
OGN icon
Organon & Co
OGN
+$1.97M
4
SPHR icon
Sphere Entertainment
SPHR
+$1.39M
5
ESPR
Esperion Therapeutics
ESPR
+$1.12M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 12.55%
3 Materials 9.73%
4 Energy 9.06%
5 Industrials 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVNA icon
1
CALL
Carvana
CVNA
$83.1B
$39.8M 13.88%
605,000
– –
TSLA icon
2
CALL
Tesla
TSLA
$1.35T
$18.3M 6.38%
43,500
– –
QQQ icon
3
PUT
Invesco QQQ Trust
QQQ
$486B
$16.9M 5.91%
23,000
+15,000
+188% +$10.3M
CVX icon
4
Chevron
CVX
$392B
$16.1M 5.61%
97,000
+22,500
+30% +$4.19M
MIST icon
5
Milestone Pharmaceuticals
MIST
$137M
$12.2M 4.24%
9,067,848
+5,000
+0.1% +$7.99K
INTU icon
6
Intuit
INTU
$94.6B
$10.1M 3.51%
+38,600
New +$13.4M
QCOM icon
7
Qualcomm
QCOM
$174B
$9.05M 3.16%
+49,000
New +$9.16M
B
8
Barrick Mining
B
$68.5B
$8.14M 2.84%
221,500
– –
TXT icon
9
Textron
TXT
$15.3B
$7.73M 2.7%
84,300
+41,600
+97% +$3.78M
REGN icon
10
Regeneron Pharmaceuticals
REGN
$82.7B
$6.17M 2.15%
9,900
+2,000
+25% +$1.36M
PLTR icon
11
CALL
Palantir
PLTR
$418B
$5.89M 2.05%
50,500
– –
NVDA icon
12
NVIDIA
NVDA
$5.45T
$5.2M 1.81%
26,000
+10,000
+63% +$2.06M
ARQT icon
13
Arcutis Biotherapeutics
ARQT
$3.29B
$4.9M 1.71%
187,000
– –
SPRY icon
14
ARS Pharmaceuticals
SPRY
$562M
$4.64M 1.62%
579,600
+3,400
+0.6% +$29.2K
MU icon
15
Micron Technology
MU
$1.1T
$4.62M 1.61%
+4,000
New +$3M
BTG icon
16
B2Gold
BTG
$6.79B
$4.42M 1.54%
1,180,000
– –
LGND icon
17
Ligand Pharmaceuticals
LGND
$5.87B
$3.51M 1.22%
11,100
– –
QQQ icon
18
CALL
Invesco QQQ Trust
QQQ
$486B
$3.31M 1.16%
4,500
– –
APP icon
19
CALL
Applovin
APP
$106B
$3.19M 1.11%
6,200
– –
CGAU
20
Centerra Gold
CGAU
$4.21B
$3.12M 1.09%
197,000
– –
NEM icon
21
Newmont
NEM
$124B
$3.04M 1.06%
32,500
– –
SLB icon
22
SLB Ltd
SLB
$79.8B
$2.84M 0.99%
61,000
+45,000
+281% +$2.41M
HRMY icon
23
Harmony Biosciences
HRMY
$2.22B
$2.66M 0.93%
73,000
– –
AVGO icon
24
CALL
Broadcom
AVGO
$1.87T
$2.64M 0.92%
7,000
– –
RPRX icon
25
Royalty Pharma
RPRX
$26.1B
$2.47M 0.86%
44,000
– –
1
2 3 4 5

Similar funds

RSC
Red Spruce Capital Berwyn, Pennsylvania $287M AUM 38.81% 1-Year Est. Return
QFW
QTR Family Wealth Lake Mary, Florida $287M AUM 40.55% 1-Year Est. Return
SRWM
Shira Ridge Wealth Management Larkspur, California $287M AUM 23.34% 1-Year Est. Return
ORC
O'Rourke & Company Boston, Massachusetts $287M AUM 23.01% 1-Year Est. Return
MPAM
Murphy Pohlad Asset Management Eden Prairie, Minnesota $287M AUM 38.81% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return
TWM
Trueblood Wealth Management Lima, Ohio $286M AUM 27.34% 1-Year Est. Return
SMTF
Sphera Management Technology Funds Tel Aviv, Israel $286M AUM 63.73% 1-Year Est. Return

Pavaki Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Pavaki Capital Management held 177 positions worth $287M, up 22% from $235M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Pavaki Capital Management deployed $39.9M of net new capital in Q2 2026, opening 21 new positions and adding to 16 existing holdings. Its largest new stake was Intuit: 38,600 shares worth $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Intel, an estimated $9.71M trimmed.

  • Pavaki Capital Management's largest Q2 2026 buy was Intuit: 38,600 shares worth $10.1M.
  • Pavaki Capital Management added most to Chevron in Q2 2026, an estimated $4.19M increase.
  • Pavaki Capital Management's biggest Q2 2026 reduction was Intel, cutting an estimated $9.71M.
  • Pavaki Capital Management fully exited Organon & Co in Q2 2026, selling an estimated $1.97M.
  • Pavaki Capital Management's ten largest holdings make up 50% of its $287M portfolio in Q2 2026.
  • Pavaki Capital Management opened 21 new positions and closed 14 in Q2 2026.
  • Pavaki Capital Management's portfolio value rose 22% quarter-over-quarter to $287M.

Based on Pavaki Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.